Company Statements
March 11, 2023
Guardant Health applauds proposed FY2024 budget increases and pledges support for the Biden-Harris Administration Moonshot goal to end cancer as we know it
Reducing the death rate from cancer by at least 50 percent over the next 25 years and improving the experience of people and families living with and surviving cancer is a hallmark of Guardant Health’s patient-first philosophy.
July 25, 2022
Guardant Health Applauds Congressional Letter Calling for HHS Action to Improve USPSTF Process to Increase Access to Cancer Screenings
Palo Alto, Calif. – July 25, 2022 – Guardant Health, a leading precision oncology company, applauds Congresswoman Anna Eshoo (D-CA) and Energy
February 4, 2022
Guardant Health Statement on Biden-Harris Administration’s Renewed Commitment to the Cancer Moonshot
Guardant Health stands with the Biden-Harris Administration’s renewed commitment to the Cancer Moonshot